Calixarenes in bio-medical researches

Current Medicinal Chemistry

Volumn 16, Issue 13, 2009, Pages 1630-1655

  Rodik, Roman V ^a   Boyko, Vyacheslav I ^a   Kalchenko, Vitaly I ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Ukraine)

Author keywords

Anticancer; Antiviral; Bactericidal; Calixarenes; Enzyme mimic; Protein complexation; Toxicity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKALI METAL; ALKALINE PHOSPHATASE; CALIX[4]ARENE; CALIX[4]ARENE BIS(METHYLENEBISPHOSPHONIC)ACID; CALIX[4]RESORCINARENE; CALIXARENE; CALIXARENE AMIDE; CALIXARENE DERIVATIVE; CALIXARENE TETRASULFONYLAMIDINE; CHIRAL CALIXARENE ACID; CHYMOTRYPSIN INHIBITOR; CYTOCHROME C ANTIBODY; ENZYME INHIBITOR; LANTHANIDE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN ANTIBODY; RESORCINARENE; TETRAKISETHOXYCARBONYLMETHYLTETRABUTYLCALIX[4]ARENE; TETRASULFONATOTETRAMETHOXYCALIX[4]ARENE; TRYPTASE INHIBITOR; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BINDING AFFINITY; BINDING SITE; CATALYSIS; CHOLINERGIC ACTIVITY; COMPLEX FORMATION; CYTOTOXICITY; DNA TRANSFECTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME SUBSTRATE COMPLEX; HUMAN; HYDROLYSIS; ION TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RNA CLEAVAGE; STRUCTURE ACTIVITY RELATION; CHEMISTRY; MEDICAL RESEARCH; MOLECULAR MIMICRY;

BIOMEDICAL RESEARCH; CALIXARENES; MOLECULAR MIMICRY;

EID: 67650215632     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788186219     Document Type: Review

References (82)

1. Moriuchi, T.; Hirao, T. Highly ordered structures of peptides by using molecular scaffolds. Chem. Soc. Rev., 2004, 33(5), 294-301.
2. Koyack, M.J.; Cheng, R.P. Design and synthesis of β-peptides with biological activity; In Protein Design Methods and Applications. Guerois, R.; López de la Paz M.; Eds Methods in Molecular Biology 2008, 340, 95-109.
3. Kilcoyne, M.; Joshi, L. Carbohydrates in therapeutics. Cardiovasc. Hematol. Agents Med. Chem., 2007, 5, 186-197.
4. Wrodnigg, T.M.; Sprenger, F.K. Bioactive carbohydrates and recently discovered analogues as chemotherapeutics. Mini Rev. Med. Chem., 2004, 4, 437-459.
5. Cal, K.; Centkowska, K. Use of cyclodextrins in topical formulations: practical aspects. Eur. J. Pharm. Biopharm., 2008, 68, 467-478.
6. Duchêne, D.; Bochot, A.; Yu, S.-C.; Pépin, C.; Seiller, M. Cyclodextrins and emulsions. Int. J. Pharm., 2003, 266, 85-90.
7. Sansone, F.; Segura, M.; Ungaro, R. Calixarenes in bioorganic and biomimetic chemistry. In Calixarenes 2001. Asfari Z.; Boehmer V.; Harowfield J.; Vicens J. Ed.; Kluwer Academic Publishers: Dodrecht, 2001;496-512.
8. Bohmer, V. Calixarenes, macrocycles with (almost) unlimited possibilities. Angew. Chem. Int. Ed. Engl., 1995, 34, 713-745.
9. De Namor, A.F.D.; Pugliese A.; Casal A.R.; Llerena M.B.; Aymonino P.J.; Velarde F.J.S. The various factors involved in the extraction of alkali metal picrates by calixarene ester derivatives in the mutually saturated water-dichloromethane solvent system. Phys. Chem. Chem. Phys., 2000, 4355-4360.
10. Talanova, G.G.; Hwang, H.-S.; Talanov, S.; Bartsch, R.A. Calix[4]arenes with a novel proton-ionizable group: Synthesis and metal ion separations. Chem. Commun., 1998, 419-420.
11. Matthews, S.E.; Parzuchowski, P.; Bohmer, V.; Garcia-Carrera, A.; Dozol J.-F.; Grüttner, C. Extraction of lanthanides and actinides by a magnetically assisted chemical separation technique based on CMPO-calix[4]arenes. Chem. Commun., 2001, 417-418.
12. Pelizzi, N.; Casnati, A.; Friggeri, A.; Ungaro, R. Synthesis and properties of new calixerene-based ditopic receptors for the simultaneous complexation of cations and carboxylate anions. J. Chem. Soc., Perkin Trans. 1, 1998, 1307-1312.
13. Budka, J.; Lhotak, P.; Michlova, V.; Stibor, I. Urea derivatives of calix4arene 1,3-alternate: An anion receptor with profound negative allosteric effect. Tetrahedron Lett., 2001, 42, 1583-1586.
14. Arena, G.; Contino, A.; Gulino, F.G.; Magri, A.; Sciotto, D.; Ungaro, R. Complexation of small neutral organic molecules by water soluble calix4arenes. Tetrahedron Lett., 2000, 41, 9327-9330.
15. Gutsche C.D. Calixarenes Revisited. The Royal Society of Chemistry: Cambridge, 1998.
16. Lumetta G.J.; Rogers R.D.; Gopalan A.S. Ed.; Calixarenes for Separations, American Chemical Society: Washington, 2000.
17. Da Silva, E.; Lazar, A.N.; Coleman, A.W. Biopharmaceutical applications of calixarenes. J. Drug. Sci. Tech., 2004, 14(1), 3-20.
18. Casnati, A.; Sansone, F.; Ungaro, R. Peptido- and glycocalixarenes: playing with hydrogen bonds around hydrophobic cavities. Acc. Chem. Res., 2003, 36, 246-254.
19. Young, M.J.; Chin, J. Dinuclear Copper (II) complex that hydrolyzes RNA. J. Am. Chem. Soc., 1995, 117, 10577-10582.
20. Molenveld, P.; Engbersen, F.J.; Kooijman, H.; Spek, A.L.; Reinhoudt, D.N. Efficient catalytic phosphate diester cleavage by the synergetic action of two Cu(II) centers in a dinuclear cis-diaqua Cu(II) calix[4]arene enzyme model. J. Am. Chem. Soc., 1998, 120, 6726-6737.
21. Molenveld, P.; Kapsabelis, S.; Engbersen, J.F.J.; Reinhoudt, D.N. Highly efficient phosphate diester transesterification by a calix[4]arene-based dinuclear Zinc(II) catalyst. J. Am. Chem. Soc. 1997, 119, 2948-2949.
22. Molenveld, P.; Stikvoort, W.M.G.; Kooijman, H.; Spek, A.L.; Engbersen, J.F.J.; Reinhoudt, D.N. Dinuclear and trinuclear Zn(II) calix[4]arene complexes as models for hydrolytic metallo-enzymes. Synthesis and catalytic activity in phosphate diester transesterification. J. Org. Chem., 1999, 64, 3896-3906.
23. Molenveld, P.; Engbersen, J.F.J.; Reinhoudt, D.N. Specific RNA dinuclear cleavage by a synthetic calix[4]arene-based trinuclear metallo(II)-phosphodiesterase. Angew. Chem. Int. Ed. Engl., 1999, 38, 3189-3192.
24. Dospil, G.; Schatz, J. Synthesis and characterization of imidazole-substituted calix[4]arenes as simple enzyme-mimics with acyltransferase activity. Tetrahedron Lett., 2001, 42, 7837-7840.
25. Magrans, J.O.; Ortiz, A.R.; Molins, M.A.; Lebouille, P.H.P.; Sanchez-Quesada, J.; Prados, P.; Pons, M.; Gaco, F.; de Mendoza, J. Designed non-peptidic receptor that mimics the phosphocholine binding site of the McPC603 antibody. Angew. Chem. Int. Ed. Engl., 1996, 35, 1712-1715.
26. Cuevas, F.; Di Stefano, S.; Magrans, J.O.; Prados, P.; Mandolini, L.; de Mendoza, J. Toward an artificial acetylcholineesterase. Chem. Eur. J., 2000, 6, 3228-3234.
27. Pollack, S.J.; Jacobs, J.W.; Schultz, P.G. Selective chemical catalysis by an antibody. Science, 1986, 234, 1570-1573.
28. Jackson, D.Y.; Prudent, J.R.; Baldwin, E.P.; Schultz, P.G. A mutagenesis study of a catalytic antibody Proc. Natl. Acad. Sci. USA, 1991, 88, 58-62.
29. Breslow, R.; Dong, S.D. Biomimetic reactions catalyzed by cyclodextrins and their cerivatives. Chem. Rev., 1998, 98, 1997-2011.
30. Murakami, Y. Functionalized cyclophanes as catalysts and enzyme models. Top. Curr. Chem., 1983, 115, 107-155.
31. Shinkai, S.; Mori, S.; Koreishi, H.; Tsubaki, T.; Manabe, O. Hexasulfonated calix6arene derivatives: A new class of catalysts, surfactants, and Host molecules. J. Am. Chem. Soc., 1986, 108, 2409-2416.
32. Gutsche, C.D.; Alam, I. Calixarenes. 23. The complexation and catalytic properties of water soluble calixarenes. Tetrahedron, 1988, 44, 4689-4694.
33. Tian-Ming, Y.; Zhi-Feng, Y.; Li, W.; Jin-Ying, G.; Si-De, Y.; Xian-Fa, S. Supramolecular interaction between water-soluble calix[4]arene and ATP - the catalysis of calix4arene for hydrolysis of ATP. Spectrochimica Acta Part A., 2002, 58, 3033-3038.
34. Shkrabak, O.A.; Kalchenko, O.I.; Rodik, R.V.; Veklich, T.O.; Kalchenko, V.I.; Kosterin, S.O. Calixarene-dependent hydrolysis of ATP. I. Kinetics and complexation of the calixarene C-107 with adenosinetriphosphate. Ukr. Biochem. J., 2008, 80(2), 90-100.
35. Shkrabak, O.A.; Veklich, T.O.; Rodik, R.V.; Boyko, V.I.; Kosterin, S.O. Calixarene-dependent hydrolysis of ATP. II. The catalytic properties of reaction stimulated by calixarene C-107. Ukr. Biochem. J., 2008, 80(3), 55-64.
36. Hamuro, Y.; Calama, M.C.; Park, H.S.; Hamilton, A.D. A calixarene with four peptide loops: An antibody mimic for recognition of protein surfaces. Angew. Chem. Int. Ed. Engl., 1997, 36, 2680-2683.
37. Wei, Y.; McLendon, G.L.; Hamilton, A.D.; Case, M.A.; Purring, C.B.; Lin, Q.; Park, H.S.; Lee, C.-S.; Yu, T. Disruption of protein-protein interactions: Design of a synthetic receptor that blocks the binding of cytochrome c to cytochrome c peroxidase. Chem. Commun., 2001, 1580-1581.
38. Mecca, T.; Consoli, G.M.L.; Geraci, C.; La Spina, R.; Cunsolo, F. Polycationic calix8arenes able to recognize and neutralize heparin. Org. Biomol. Chem., 2006, 4, 3763-3768.
39. Schneider, H.-J.; Schneider, U. Inhibition of choline acetate hydrolysis in the presence of a macrocyclic polyphenolate. J. Org. Chem., 1987, 52, 1613-1615.
40. Schneider, U.; Schneider, H.-J. Synthese und eigenschaften von makrocyclen aus resorcinen sowie von entsprechenden derivaten und wirt-gast-komplexen. Chem. Ber., 1994, 127, 2455-2469.
41. Vovk, A.I.; Kalchenko, V.I.; Cherenok, S.A.; Kukhar, V.P.; Muzychka, O.V.; Lozynsky, M.O. Calix[4]arene methylenebisphosphonic acids as calf intestine alkaline phosphatase inhibitors. Org. Biomol. Chem., 2004, 2, 3162-3166.
42. Cherenok, S.; Vovk, A.; Muravyova, I.; Shivanyuk, A.; Kukhar, V.; Lipkowski, J.; Kalchenko, V. Calix4arene α-aminophosphonic acids: asymmetric synthesis and enantioselective inhibition of an alkaline phosphatase. Organic Lett., 2006, 8, 549-552.
43. Park, H.S.; Lin, Q.; Hamilton, A.D. Protein surface recognition by synthetic receptors: A route to novel submicromolar inhibitors for α-chymotripsin. J. Am. Chem. Soc., 1999, 121, 8-13.
44. Park, H.S.; Lin, Q.; Hamilton, A.D. Modulation of protein-protein interactions by synthetic receptors: Design of molecules that disrupt serine protease-proteinaceous inhibitor interaction. Proc. Natl. Acad. Sci. USA, 2002, 99, 5105-5109.
45. Mecca, T.; Consoli, G.M.L.; Geraci, C.; Cunsolo, F. Designed calix[8]arene-based ligands for selective tryptase surface recognition. Bioorg. Med. Chem., 2004, 12, 5057-5062.
46. Murillo, O.; Watanabe, S.; Nakano, A.; Gokel, G.W. Synthetic models for transmembrane channels: Structural variations that altercation flux. J. Am. Chem. Soc., 1995, 117, 7665-7669.
47. + transport through phospholipid bilayer membrane by a synthetic calix[4]arene carrier. Langmuir, 1996, 12, 2684-2689.
48. Jin, T.; Kinjo, M.; Kobayashi, Y.; Hirata, H. Ion transport activity of calix[n]arene (n = 4, 5, 6, 7, 8) esters toward alkali-metal cations in a phospholipid bilayer membrane. J. Chem. Soc. Faraday Trans., 1998, 94, 3135-3140.
49. de Mendoza, J.; Cuevas, F.; Prados, P.; Meadows, E.S.; Gokel, G.W. Synthetic cation-transporting calix4arene derivative active in phospholipid bilayers. Angew. Chem. Int. Ed. Engl., 1998, 37, 1534-1537.
50. + selectivity. Angew. Chem. Int. Ed. Engl., 1995, 34, 693-694.
51. Kobuke, Y.; Nagatani, T. A supramolecular ion channel based on amphiphilic cholic acid derivatives. Chem. Lett., 2000, 298-306.
52. Yoshino, N.; Satake, A.; Kobuke, Y. An artificial ion channel formed by a macrocyclic resorcin[4]arene with amphiphilic cholic acid ether groups. Angew. Chem. Int. Ed. Engl., 2001, 40, 457-459.
53. 2+ accumulation in the smooth muscle subcellular structures. J. Incl. Phenom., 2008, 60, 131-137.
54. 2+, ATP-dependent calcium pumps. Tetrahedron Lett., 2005, 46, 7459.
55. 2+-dependent ATP-hydrolase enzymatic systems from smooth muscle cells of the uterus. Ukr. Biochem. J., 2007, 79(3), 44-54.
56. +-ATPase activity in plasma membranes of the smooth-muscle cells. Ukr. Biochem. J., 2006, 78(1), 70-86.
57. +-ATPase activity in plasmatic membrane of smooth muscle cells. Ukr. Biochem. J., 2006, 78(6), 53-63.
58. Singh, A.K.; Venglarik, C.J.; Bridges, R.J. Development of chloride channel modulators. Kidney Int., 1995, 48, 985-993.
59. Droogmans, G.; Prenen, J.; Eggermont, J.; Voets, T.; Nilius, V. Voltage-dependent block of endotelial volume-regulated anion channels by calix[4]arenes. Am. J. Physiol., 1998, 275, c646-c652.
60. Edwards, J.C.; Tulk, B.; Schlesinger, P.H. Functional expression of p64, an intracellular chloride channel protein. J. Membrane Biol., 1998, 163, 119-127.
61. Atwood, J.L.; Bridges, R.J.; Juneja, R.K.; Singh, A.K. Calixarene chloride-channel blockers Patent US 5489612, 1996.
62. Cho, Y.R.; Maguire, A.J.; Try, A.C.; Westwell, M.S.; Groves, P.; Williams, D.H. Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics. Chem. Biol., 1996, 3, 207-215
63. Casnati, A.; Fabbi, M.; Pelizzi, N.; Pochini, A.; Francgesco, S.; Ungaro, R.; di Modugno, E.; Tarzia, G. Synthesis, antimicrobial activity and binding properties of calix[4]arene based Vancomycin mimics. Bioorg. Med. Chem. Lett., 1996, 6, 2699-2704.
64. Frish, L.; Sansone, F.; Casnati, A.; Ungaro, R.; Cohen, Y. Complexation of peptidocalix4arene, a Vancomycin mimic, with Alanine-containing Guests by NMR diffusion measurements. J. Org. Chem., 2000, 65, 5026-5030.
65. Hart, P.D.; Armstrong, J.A.; Brodaty, E. Calixarenes with Host-mediated potency in experimental tuberculosis: Further evidence that macrophage lipids are involved in their mechanism of action. Infect. and Immun., 1996, 64, 1491-1493.
66. Paquet, V.; Zumbuehl, A.; Carreira, E.M. Biologically active Amphotericin B-calix[4]arene conjugates. Bioconjug. Chem., 2006, 17, 1460-1463.
67. Hwang, K.M.; Qi, Y.M.; Liu, S.-Y. Aryl macrocyclic compositions for treating viral infections. Patent US5312837, 1994.
68. Hwang, K.M.; Qi, Y.M.; Liu, S.-Y.; Thomas, B.; Lee, C.; Bruno, S.; Choy W.; Chen, J. antitrombothic treatment with calix[n]arene compounds. Patent US5409959, 1995.
69. Fujimoto, K.; Miyata, T.; Aoyama, Y. Saccharide-directed cell recognition and molecular delivery using macrocyclic saccharide clusters: Masking of hydrophobicity to enhance the saccharide specificity. J. Am. Chem. Soc., 2000, 122, 3558-3559.
70. Menger, F.M.; Bian, J.; Sizova, E.; Martinson, D.E.; Seredyuk, V.A. Bolaforms with fourteen galactose units: A proposed site-directed cohesion of cancer cells. Org. Lett., 2004, 6, 261-264.
71. Zhou, H.; Wang, D.; Baldini, L.; Ennis, E.; Jain, R.; Carie, A.; Sebti, S.M.; Hamilton, A.D. Structure-activity studies on a library of potent calix4arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation. Org. Biomol. Chem., 2006, 4, 2376-2386.
72. Dings, R.P.M.; Chen, X.; Hellebrekers, D.M.E.I.; van Eijk, L.I.; Zhang, Y.; Hoye, T.R.; Griffioen, A.W.; Mayo, K.H. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities. J. Natl. Cancer Inst., 2006, 98, 932-936.
73. Srinivasachari, S.; Fichter, K. M.; Reineke, T. M. Polycationic β-cyclodextrin "click clusters": Monodisperse and versatile scaffolds for nucleic acid delivery. J. Am. Chem. Soc., 2008, 130, 4618-4627.
74. Lalor, R.; DiGesso, J.L.; Mueller, A.; Matthews, S.E. Efficient gene transfection with functionalized multicalixarenes. Chem. Commun., 2007, 4907-4909.
75. Bagnacani, V.; Sansone, F.; Donofrio, G.; Baldini, L.; Casnati, A.; Ungaro, R. Macrocyclic nonviral vectors: High cell transfection efficiency and low toxicity in a lower rim guanidinium calix[4]arene. Org. Lett., 2008, 10, 3953-3956.
76. See http://www.invitrogen.com/downloads/F-069843-LpofctLTX_FHR.pdf.
77. III complex endowed with high stability, relaxivity, and binding affinity to serum albumin. Angew. Chem. Int. Ed. Engl., 2001, 40, 4737-4739.
78. Gutsche, C.D. Calixarenes. In Host Guest Complex Chemistry Macrocycles; Synthesis, Structures, Applications. Vögtle F.; Weber E. Eds.; Springer: Tokyo, 1985.
79. Perret, F.; Mazzorana, M.; Shahgaldian, P.; Coleman, A.W. First step in the study of the cellular toxicity of the calixarene. Abstracts, ISSC XI, Fukuoka, 2000, PB-26, 387.
80. Shahgaldian, P.; Da Silva, E.; Coleman, A.W. A first approach to the study of calixarene solid lipid nanoparticle (SLN) toxicity. J. Incl. Phenom., 2003, 46, 175-177.
81. Memisoglu, E.; Bochot, A.; Oezalp, M.; Sen, M.; Duchene, D.; Hincal, A.A. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharm. Res., 2003, 20, 117-125.
82. Da Silva, E.; Shahgaldian, P.; Coleman, A.W. Haemolytic properties of some water-soluble para-sulphonato-calix- i n]-arenes. Int. J. Pharm., 2004, 273, 57-62.